샘플 요청 목록

 카트 문의
시장보고서
상품코드
1514140

세계의 통증 관리 기기 시장

Pain Management Devices
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 118 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 통증 관리 기기 시장은 2030년까지 50억 달러에 달할 전망

2023년에 30억 달러로 평가된 세계의 통증 관리 기기 시장은 분석 기간 2023년부터 2030년까지 CAGR 7.7%로 성장할 전망이며, 2030년에는 50억 달러에 이를 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 신경자극장치는 CAGR 8.3%로 성장을 지속하고, 분석 기간 종료 시에는 35억 달러에 달할 것으로 예측됩니다. 주입 펌프 분야의 성장률은 분석 기간 동안 CAGR 6.5%로 추정됩니다.

미국 시장은 7억 7,330만 달러로 추정, 중국은 CAGR 11.6%로 성장 예측

미국의 통증 관리 기기 시장은 2023년 7억 7,330만 달러로 평가되었습니다. 세계 2위 경제대국인 중국은 분석 기간 2023년부터 2030년까지 CAGR 11.6%로 전망되며, 2030년까지 시장 규모 12억 달러에 달할 것으로 예측되고 있습니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 3.7%와 6.9%로 예측되고 있습니다. 유럽에서는 독일이 CAGR 4.6%로 성장할 것으로 예측됩니다.

세계의 통증 관리 기기 시장-주요 동향 및 촉진요인 요약

통증 관리 기기는 전통적인 건강 관리 접근법에 과제를 초래하는 복잡하고 지속적인 증상인 만성 통증을 다루는 매우 중요한 요소로 부상하고 있습니다. 척수 자극 장치 및 척수강 펌프와 같은 침습적 임플란트에서 TENS 유닛 및 모바일 애플리케이션과 같은 비침습적 도구에 이르기까지 이러한 장치는 안전성과 비중독성을 결합한 치료법의 새로운 길을 제공합니다. 특히 수술 후 만성 요통과 같은 통증 관리에 유익하며, 이러한 기술은 통증 수용체를 직접 표적화하거나 통증 신호 경로를 변화시킴으로써 의약품의 필요성을 크게 줄일 수 있습니다. 말초 신경 자극이나 가상현실과 같은 비침습적 기술과 같은 혁신은 전통적인 통증 관리법에 흔한 전신적 부작용 없이 완화를 가져오고 치료 상황을 더욱 다양화하고 있습니다.

통증 관리 기기 시장은 도입과 효과를 높이는 몇 가지 중요한 요소에 의해 확대되고 있습니다. 기기 기술의 발전은 이러한 도구의 기능과 사용 편의성을 더욱 정교하게 만들고, 무선 연결 및 스마트폰과의 통합과 같은 최첨단 기능을 계속 통합하고 있습니다. 이러한 기술 진보는 만성 통증이 공중 보건에 중요한 문제라는 인식이 높아지고 혁신적이고 효과적인 관리 전략에 대한 수요가 증가하는 것과 나란히 하고 있습니다. 게다가 세계의 노화와 진행중인 오피오이드 위기는 중독의 위험 없이 통증에 대처하는 대체 요법의 필요성을 강조하고, 장비를 바람직한 선택으로 추진하고 있습니다. 이러한 요소는 규제 정책과 보험 적용 범위가 확대됨에 따라 통증 관리 기기에 대한 접근과 의존을 촉진합니다.

통증 관리 기기의 미래는 효과적이고 안전한 환자 중심 치료의 필요성을 뒷받침하고 유망시되고 있습니다. 만성 통증의 확산이 증가함에 따라 정확하고 개별화 된 통증 완화를 제공하는 고급 기술 개발의 중요성도 커지고 있습니다. 지속적인 기술 혁신은 환자 참여와 치료 규정 준수를 향상시키는 디지털 도구의 통합을 촉진할 것으로 예상됩니다. 그러나 이러한 장비의 효능은 진정한 치료 효과와 위약 효과를 구별하기 위한 엄격한 임상 조사에 뒷받침되어야 합니다. 통증 관리 기기의 지속적인 진화는 기술의 진보뿐만 아니라보다 효과적인 치료를 제공하는 것을 목표로 한 통증 생리학의 깊은 이해를 반영합니다. 이 분야는 현대 건강 관리에서 만성 통증을 관리하는 방법을 변화시키는 최전선의 기술과 환자 중심 전략으로 크게 확대될 것입니다.

조사 대상 기업 예(총 34건)

  • Baxter International, Inc.
  • Bio-Medical Research(BMR) Ltd.
  • Boston Scientific Corporation
  • Halyard Health, Inc.
  • Stryker Corporation

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향 및 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동
  • 아프리카

제4장 경쟁

AJY 24.07.24

Global Pain Management Devices Market to Reach US$5.0 Billion by 2030

The global market for Pain Management Devices estimated at US$3.0 Billion in the year 2023, is expected to reach US$5.0 Billion by 2030, growing at a CAGR of 7.7% over the analysis period 2023-2030. Neurostimulation Devices, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$3.5 Billion by the end of the analysis period. Growth in the Infusion Pumps segment is estimated at 6.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$773.3 Million While China is Forecast to Grow at 11.6% CAGR

The Pain Management Devices market in the U.S. is estimated at US$773.3 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$1.2 Billion by the year 2030 trailing a CAGR of 11.6% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.7% and 6.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.6% CAGR.

Global Pain Management Devices Market - Key Trends and Drivers Summarized

Pain management devices are emerging as a pivotal element in addressing chronic pain, a complex and persistent condition that challenges traditional healthcare approaches. These devices, ranging from invasive implants like spinal cord stimulators and intrathecal pumps to noninvasive tools such as TENS units and mobile applications, offer new avenues for treatment, combining safety with non-addictive properties. Particularly beneficial in managing conditions like chronic back pain post-surgery, these technologies also significantly reduce the need for pharmaceuticals by directly targeting pain receptors or altering pain signal pathways. Innovations such as peripheral nerve stimulation and noninvasive techniques like virtual reality further diversify the treatment landscape, providing relief without the systemic side effects often associated with traditional pain management methods.

The market for pain management devices is expanding, driven by several key factors that enhance their adoption and effectiveness. Advances in device technology continue to refine the functionality and user-friendliness of these tools, integrating cutting-edge features like wireless connectivity and smartphone integration. This technological progression is paralleled by increasing recognition of chronic pain as a significant public health issue, which has elevated demand for innovative and effective management strategies. Furthermore, the aging global population and the ongoing opioid crisis underscore the need for alternative therapies that address pain without the risk of addiction, promoting devices as preferable options. These elements, combined with supportive regulatory policies and broader insurance coverage, facilitate greater access to and reliance on pain management devices.

The future of pain management devices looks promising, fueled by the necessity for effective, safe, and patient-centered treatment modalities. As the prevalence of chronic pain rises, so does the importance of developing advanced technologies that offer precise and personalized pain relief. Continued innovation is expected to drive the integration of digital tools that enhance patient engagement and treatment compliance. However, the effectiveness of these devices must be underpinned by rigorous clinical research to differentiate true therapeutic benefits from placebo effects. The ongoing evolution of pain management devices not only reflects advancements in technology but also a deeper understanding of pain physiology, aiming to provide more targeted and effective treatments. This field is set to expand significantly, with technology and patient-centric strategies at the forefront of transforming how chronic pain is managed in contemporary healthcare.

Select Competitors (Total 34 Featured) -

  • Baxter International, Inc.
  • Bio-Medical Research (BMR) Ltd.
  • Boston Scientific Corporation
  • Halyard Health, Inc.
  • Stryker Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Pain Management Devices - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Strong Market for Home Healthcare Devices Provides the Foundation for Growth
    • Increasing Prevalence of Chronic Pain Conditions Drives Market Growth
    • Technological Innovations in Pain Management Devices Propel Demand
    • Rising Geriatric Population Expands Addressable Market Opportunity
    • Non-invasive Pain Relief Solutions Strengthen Business Case
    • Integration of Wearable Technology in Pain Management Generates Demand
    • Advancements in Neurostimulation Devices Accelerate Market Growth
    • Rise in Sports Injuries and Accidents Drives Adoption of Pain Management Devices
    • Increasing Awareness of Pain Management Solutions. This is How it Impacts the Market
    • E-commerce Platforms Expand Market Reach
    • Personalized Pain Management Devices Spur Customized Healthcare Solutions
    • Development of Portable and User-friendly Devices Strengthens Market Demand
    • Rise in Post-surgical Pain Management Needs Accelerates Market Growth
    • Focus on Improving Patient Quality of Life Drives Adoption
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Pain Management Devices Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Pain Management Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Pain Management Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Pain Management Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Neurostimulation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Neurostimulation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Neurostimulation Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Infusion Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Infusion Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Infusion Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Ablation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Ablation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Ablation Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Neuropathic Pain by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Neuropathic Pain by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Neuropathic Pain by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Cancer Pain by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Cancer Pain by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Cancer Pain by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Facial Pain & Migraine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Facial Pain & Migraine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Facial Pain & Migraine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Musculoskeletal Pain by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Musculoskeletal Pain by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Musculoskeletal Pain by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Pain Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • JAPAN
    • Pain Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Japan 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • CHINA
    • Pain Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 47: China Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: China 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: China 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • EUROPE
    • Pain Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Pain Management Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Pain Management Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Pain Management Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • FRANCE
    • Pain Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: France 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 65: France Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: France 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • GERMANY
    • Pain Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Germany 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Italy 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Pain Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 83: UK Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: UK 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Spain 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Spain 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Russia 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Russia 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Rest of Europe 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Rest of Europe 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Pain Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Pain Management Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Pain Management Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Pain Management Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Asia-Pacific 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Asia-Pacific 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Pain Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Australia 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: Australia 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • INDIA
    • Pain Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 119: India Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: India 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 122: India Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: India 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: South Korea 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: South Korea 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Pain Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Pain Management Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Pain Management Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Pain Management Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Latin America 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Latin America 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Argentina 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Argentina 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Brazil 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Brazil 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Mexico 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Mexico 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Rest of Latin America 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Rest of Latin America 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Pain Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Pain Management Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Pain Management Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Pain Management Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Middle East 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Middle East 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Iran 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Iran 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Israel 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Israel 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: Saudi Arabia 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: Saudi Arabia 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: UAE 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: UAE 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Rest of Middle East 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: Rest of Middle East 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030
  • AFRICA
    • Pain Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Pain Management Devices by Type - Neurostimulation Devices, Infusion Pumps and Ablation Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 211: Africa 16-Year Perspective for Pain Management Devices by Type - Percentage Breakdown of Value Sales for Neurostimulation Devices, Infusion Pumps and Ablation Devices for the Years 2014, 2024 & 2030
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Pain Management Devices by Application - Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 214: Africa 16-Year Perspective for Pain Management Devices by Application - Percentage Breakdown of Value Sales for Neuropathic Pain, Cancer Pain, Facial Pain & Migraine, Musculoskeletal Pain and Other Applications for the Years 2014, 2024 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제